Your browser is no longer supported. Please, upgrade your browser.
Settings
ETRM EnteroMedics Inc. daily Stock Chart
ETRM [NASD]
EnteroMedics Inc.
Index- P/E- EPS (ttm)-114.49 Insider Own- Shs Outstand6.76M Perf Week-3.25%
Market Cap38.19M Forward P/E- EPS next Y- Insider Trans- Shs Float6.76M Perf Month-2.75%
Income-23.40M PEG- EPS next Q- Inst Own4.20% Short Float16.98% Perf Quarter12317.58%
Sales0.80M P/S47.74 EPS this Y87.40% Inst Trans129.12% Short Ratio0.27 Perf Half Y3681.79%
Book/sh1.76 P/B3.21 EPS next Y- ROA-196.90% Target Price140.00 Perf Year482.47%
Cash/sh0.49 P/C11.57 EPS next 5Y0.24% ROE- 52W Range0.04 - 30.41 Perf YTD182.50%
Dividend- P/FCF- EPS past 5Y47.10% ROI-786.10% 52W High-81.42% Beta2.26
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin45.20% 52W Low14025.00% ATR0.46
Employees32 Current Ratio1.40 Sales Q/Q0.00% Oper. Margin- RSI (14)38.01 Volatility5.29% 8.23%
OptionableYes Debt/Eq0.00 EPS Q/Q96.00% Profit Margin- Rel Volume0.04 Prev Close5.70
ShortableYes LT Debt/Eq0.00 EarningsMar 07 BMO Payout- Avg Volume4.26M Price5.65
Recom2.00 SMA20-7.69% SMA50-17.83% SMA200142.97% Volume155,256 Change-0.88%
Jun-09-16Downgrade ROTH Capital Buy → Neutral $3 → $0.50
Dec-03-13Reiterated Northland Capital Outperform $3 → $7
Jun-29-12Initiated Northland Securities Outperform $4.50
Jan-09-09Downgrade Argus Hold → Sell
Jan-03-08Initiated Cowen & Co Neutral
Mar-16-17 11:35AM  EnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
Mar-15-17 02:10PM  EnteroMedics, Inc. :ETRM-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-14-17 01:04PM  ENTEROMEDICS INC Financials
12:18PM  Here's Why EnteroMedics (ETRM) Stock Soared Today
Mar-13-17 04:30PM  EnteroMedics' vBloc® Neurometabolic Therapy Featured on "The Doctors" TV Show PR Newswire
Mar-08-17 05:29PM  ENTEROMEDICS INC Files SEC form 10-K, Annual Report
Mar-07-17 07:59AM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:20AM  EnteroMedics reports 4Q loss
07:00AM  EnteroMedics Reports Fourth Quarter 2016 Financial Results PR Newswire
Feb-21-17 05:19PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -7.13%
01:56PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating EnteroMedics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
07:00AM  EnteroMedics Regains Compliance With Nasdaq Listing Requirement PR Newswire
Feb-14-17 06:00PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-09-17 07:00AM  EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity PR Newswire +14.47%
Jan-31-17 04:18PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events
Jan-24-17 04:03PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-23-17 11:00AM  EnteroMedics Announces Closing of $19.0 Million Underwritten Public Offering and Full Exercise of Over-allotment Option PR Newswire
Jan-12-17 09:39AM  Biotech Movers: Illumina, Inc. (ILMN) And EnteroMedics Inc (ETRM) at Insider Monkey -8.50%
Jan-10-17 05:02PM  Stock Market Roundup, Jan. 10: NVDA Self-Driving Cars, ETRM Soars +56.50%
01:38PM  Still Struggling to Put Money to Work
09:30AM  EnteroMedics and GenVec Post Substantial Gains as the NASDAQ is Pushed to Record High Accesswire
Jan-09-17 03:31PM  Biotech Movers: EnteroMedics Inc (ETRM) And Stemline Therapeutics Inc (STML) at Insider Monkey +92.60%
01:33PM  Bullish and Bearish Reversals in the Market
Jan-05-17 02:55PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +89.95%
11:40AM  Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday
07:00AM  EnteroMedics Announces vBloc® Neurometabolic Therapy Now Available at MedStar Health and Roper St. Francis PR Newswire
Dec-30-16 05:50PM  Why U.S. Steel, EnteroMedics, and McEwen Mining Slumped Today at Motley Fool -18.03%
Dec-29-16 07:03AM  Splits Calendar: EnteroMedics splits before market open today (70:1 ratio)
07:00AM  EnteroMedics Announces Retirement of All Senior Convertible Notes PR Newswire
Dec-28-16 11:11AM  ENTEROMEDICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, F +5,890.34%
Dec-27-16 08:15AM  Blog Coverage EnteroMedics Announced 1-for-70 Reverse Stock Split and Amortization of its Convertible Notes Accesswire -9.01%
Dec-23-16 07:24AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -7.52%
07:00AM  EnteroMedics Announces 1-for-70 Reverse Stock Split PR Newswire
Dec-20-16 01:52PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -6.19%
Dec-15-16 07:00AM  Commercial Patient Data Confirms Success of EnteroMedics' vBloc® Therapy in Combination with vBloc® Achieve Program in Patients Struggling to Lose Weight PR Newswire
Dec-13-16 06:03AM  ENTEROMEDICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of M -11.08%
Dec-05-16 05:02PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +7.42%
Nov-30-16 07:00AM  EnteroMedics to Host vBloc® Therapy Commercialization and Corporate Update Conference Call PR Newswire -22.06%
Nov-22-16 02:41PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +98.89%
07:00AM  EnteroMedics Provides Commercialization and Corporate Update PR Newswire
Nov-16-16 04:46PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events
Nov-14-16 02:06PM  ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report
Nov-11-16 12:10PM  EnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 -12.59%
Nov-10-16 08:08AM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +31.07%
07:00AM  EnteroMedics Reports Third Quarter 2016 Financial Results PR Newswire
Nov-08-16 05:29PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers -15.42%
Nov-01-16 04:23PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events -10.71%
04:01PM  Live Rescue Surgery Implanting vBloc® for Failed Gastric Sleeve to be Broadcast at ObesityWeek 2016 Conference PR Newswire
Oct-19-16 04:28PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events +7.11%
Oct-14-16 06:05AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -6.72%
Oct-13-16 12:37PM  EnteroMedics Urges Shareholders to Vote for Proposed Amendments at October 19 Special Shareholder Meeting PR Newswire
Oct-11-16 07:45AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  EnteroMedics Highlights Recent Achievements Ahead of Special Shareholder Meeting PR Newswire
Oct-08-16 01:04PM  ENTEROMEDICS INC Financials
Oct-06-16 01:50PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements an
Oct-05-16 07:00AM  EnteroMedics Announces Partner's National VA Contract Includes vBloc® Therapy for the Treatment of Obesity PR Newswire +5.28%
Sep-27-16 07:47AM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits +8.77%
07:00AM  EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors PR Newswire
Sep-21-16 07:00AM  EnteroMedics to Present at the Ladenburg Thalmann Healthcare Conference PR Newswire
Sep-20-16 04:13PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Sep-19-16 07:00AM  EnteroMedics Announces Receipt of Notice of Intention to Grant European Patent Covering Safety Features of vBloc® Therapy Strengthening Company's Neuromodulation Intellectual Property Portfolio of More than 70 Patents Worldwide PR Newswire +22.43%
Sep-13-16 07:00AM  vBloc Institute Demonstrates Positive Clinical Success in Patients Struggling with Weight Loss as Compared to Pivotal FDA Trial with EnteroMedics vBloc® Therapy in Combination with vBloc® Achieve Program PR Newswire
Sep-12-16 05:09PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Sep-07-16 07:00AM  EnteroMedics Announces Appointment of Scott Youngstrom as Chief Financial Officer and Chief Compliance Officer PR Newswire
Aug-17-16 04:50PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements an
07:00AM  EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors PR Newswire
Aug-15-16 07:00AM  EnteroMedics Announces Publication of 24 Month ReCharge Clinical Study Data in Obesity Surgery PR Newswire
Aug-12-16 08:04AM  ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report
Aug-11-16 11:37AM  EnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-04-16 07:49AM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:00AM  EnteroMedics Reports Second Quarter 2016 Financial Results PR Newswire
Jul-20-16 05:21PM  ENTEROMEDICS INC Files SEC form 8-K, Other Events
Jul-15-16 06:04AM  ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -27.78%
Jul-13-16 12:08PM  Cheap Stocks: These Aren't Necessarily a Lucky 7 +35.48%
Jul-06-16 05:11PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers +12.00%
Jun-29-16 07:00AM  EnteroMedics Highlights Recent Patient Success with vBloc® Therapy in Combination with vBloc® Achieve Program PR Newswire -6.67%
Jun-28-16 06:04AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events -9.09%
Jun-09-16 08:52AM  EnteroMedics downgraded by ROTH Capital
Jun-01-16 07:00AM  EnteroMedics Announces First-of-its-Kind Procedure with vBloc® Therapy Used as Adjunctive Rescue Treatment for Failed Gastric Sleeve in Patients with Obesity PR Newswire -7.55%
May-23-16 07:00AM  EnteroMedics to Host vBloc® Commercialization Update Conference Call PR Newswire
May-13-16 05:09PM  ENTEROMEDICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; -5.97%
May-10-16 05:18PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers
May-06-16 06:13AM  ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial
May-05-16 04:19PM  EnteroMedics Reports First Quarter 2016 Financial Results PR Newswire
May-03-16 07:00AM  EnteroMedics Announces Closing of $6.25 Million Third Tranche of Previously-Announced Convertible Notes Offering PR Newswire -6.25%
May-02-16 07:00AM  EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc® Neurometabolic Therapy to US Department of Veterans Affairs Medical Facilities PR Newswire
Apr-21-16 07:00AM  Weight Loss Surgery Foundation of America to Include EnteroMedics vBloc® Therapy as Part of the Grant Referral Program PR Newswire +5.32%
Apr-05-16 02:44PM  EnteroMedics Announces Publication of Results Showing Significantly Greater Weight Loss in vBloc® Patients with Moderate Obesity PR Newswire
Mar-28-16 05:24PM  ENTEROMEDICS INC Files SEC form 10-K, Annual Report -7.77%
Mar-09-16 07:00AM  EnteroMedics to Present at the 28th Annual ROTH Conference PR Newswire
Feb-17-16 07:40AM  ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:17AM  EnteroMedics reports 4Q loss
07:00AM  EnteroMedics Reports Fourth Quarter 2015 Financial Results PR Newswire
Feb-16-16 10:02AM  EnteroMedics Named One of Fast Company's Top Ten Most Innovative Companies in Biotech for 2016 PR Newswire +22.22%
Feb-03-16 07:00AM  EnteroMedics to Host Fourth Quarter 2015 Financial Results and Commercialization Update Conference Call PR Newswire +23.26%
06:05AM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements an
Feb-02-16 05:43PM  Winthrop-University Hospital Becomes First Employer in the U.S. to Cover Innovative Obesity Treatment vBloc Therapy PR Newswire
Jan-22-16 05:28PM  ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements an
05:21PM  EnteroMedics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Jan-13-16 07:26AM  ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -13.10%
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeLange Peter M.SVP, Ops & Bus DevJun 03Buy0.5520,00011,00027,373Jun 06 04:35 PM